Key facts
- Aurora Cold Plasma Sterilisation’s last known valuation is $10.1M (Feb 2023).
- It has raised $9.9M; the latest was Later Stage VC ($4.4M) in Nov 2025.
- Notable investors include European Innovation Council, GO Capital, Government of Francaise, Normandie Business Angels, Normandie Participations — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Aurora Cold Plasma Sterilisation
- ·The full record, as it builds
Funding rounds
No funding rounds for Aurora Cold Plasma Sterilisation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aurora Cold Plasma Sterilisation
Developer of sterilizers designed for sterilizing fragile or complex medical devices at room temperature with gas from the air. The company offers plasma sterilizing devices based on low-pressure air gas plasma generation, enabling patients to protect themselves from exposed non-sterilized endoscopic contamination.
- Sector
- Healthcare
- HQ
- Rouen, France
- Founded
- 2019
- Employees
- 32
- Website
- aurora-sterilisation.com/
- Ownership
- Privately Held (backing)
Aurora Cold Plasma Sterilisation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aurora Cold Plasma Sterilisation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aurora Cold Plasma Sterilisation in its N-PORT filings yet. We sweep new filings monthly.